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Rift Valley fever virus (RVFV) causes disease outbreaks across Africa and the Arabian
Peninsula, resulting in high morbidity and mortality among young domestic livestock,
frequent abortions in pregnant animals, and potentially severe or fatal disease in
humans. The possibility of RVFV spreading to the United States or other countries
worldwide is of significant concern to animal and public health, livestock production,
and trade. The mechanism for persistence of RVFV during inter-epidemic periods may
be through mosquito transovarial transmission and/or by means of a wildlife reservoir.
Field investigations in endemic areas and previous in vivo studies have demonstrated
that RVFV can infect a wide range of animals, including indigenous wild ruminants
of Africa. Yet no predominant wildlife reservoir has been identified, and gaps in our
knowledge of RVFV permissive hosts still remain. In North America, domestic goats,
sheep, and cattle are susceptible hosts for RVFV and several competent vectors
exist. Wild ruminants such as deer might serve as a virus reservoir and given their
abundance, wide distribution, and overlap with livestock farms and human populated
areas could represent an important risk factor. The objective of this study was to
assess a variety of cell lines derived from North American livestock and wildlife for
susceptibility and permissiveness to RVFV. Results of this study suggest that RVFV could
potentially replicate in native deer species such as white-tailed deer, and possibly a wide
range of non-ruminant animals. This work serves to guide and support future animal
model studies and risk model assessment regarding this high-consequence zoonotic
pathogen.
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Introduction
Rift Valley fever virus (RVFV) belongs to the genus Phlebovirus in the family Bunyaviridae, and is a
vector transmitted pathogen that causes endemic disease across Africa and the Arabian Peninsula
(Balkhy and Memish, 2003; Grobbelaar et al., 2011). Periodic outbreaks of the disease coincide
with heavy rainfall and ﬂooding conditions which allow for increased breeding of blood-feeding
mosquitoes which are the primary vectors for this viral pathogen (Davies et al., 1985; Linthicum
et al., 1985; Grobbelaar et al., 2011). RVFV threatens both human and animal health, and has costly
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economic impact related to livestock production and trade. In
aﬀected countries, RVFV causes outbreaks of high morbidity and
mortality among young domestic sheep, goats, and cattle, and
numerous abortions in pregnant animals (Coetzer, 1977, 1982;
Pepin et al., 2010). Humans can also become infected, primarily
through contact with infectious animal ﬂuids and tissues. Disease
in humans can be mild to severe and in some cases fatal
(Pepin et al., 2010; Ikegami and Makino, 2011). Human patients
infected with RVF may suﬀer from a self-limiting, febrile illness,
or in more severe cases develop hemorrhagic fever, hepatitis,
neurologic disorders, or blindness (Ikegami and Makino, 2011).
The human mortality rate varies, but is estimated at 1% of
those infected with RVFV. However, fatalities reaching 29% was
documented for the RVFV outbreak in east Africa during 2006–
2007 (Pepin et al., 2010).
The potential of RVFV spreading to the United States (US) or
other countries worldwide, whether by accident or with intent,
is of signiﬁcant concern (Ahmed et al., 2009; Hartley et al.,
2011). Several genera of mosquitoes present in the US have been
identiﬁed as potential competent vectors for this virus (Turell
et al., 2008, 2010; Iranpour et al., 2011). Field investigations for
seroprevalence in indigenous wildlife of endemic countries and
a limited number of animal model studies have demonstrated
that RVFV is capable of infecting a wide range of wild animal
species (Olive et al., 2012). The major mechanism for persistence
of RVFV during inter-epidemic periods is putatively through
infected adult mosquitoes passing the virus to their oﬀspring
by transovarial transmission (Linthicum et al., 1985), but could
also be by means of a wildlife reservoir, as in the case of West
Nile virus (Blitvich, 2008). However, to date, no predominant
wildlife reservoir has been identiﬁed for RVFV, and gaps in our
knowledge of permissive hosts still remain, especially concerning
the Americas (Hartley et al., 2011).
Wild ruminants in North America, such as deer, could
represent an important risk factor given their abundance, wide
distribution, and overlap with livestock farms and human
populated areas (Kasari et al., 2008; Kakani et al., 2010). Although
mosquitoes may have host preferences, they are opportunistic
feeders which could facilitate transmission between proximal
wildlife, livestock, and human populations (Molaei et al., 2008,
2009a,b). If RVFV were to be introduced into the US and wildlife
became infected, it could dramatically impact the establishment
and dissemination of this disease (Kasari et al., 2008; Kakani
et al., 2010). To date, the susceptibility of native wildlife species
inhabiting the US to RVFV has not been investigated and the
potential role of these animals in RVF epidemiology remains
widely unknown (Hartley et al., 2011). Knowing potential hosts
of RVFV is important for determining the epidemiological risk
and creating accurate prediction models for eﬀective response
and control strategies. In the current study, a variety of cell lines
derived from native livestock and wildlife found throughout the
US were tested for RVFV susceptibility and permissiveness. Initial
experiments were performed with a vaccine strain of RVFV (MP-
12) followed by comparison with a virulent wild type RVFV
strain (SA01-1322) in representative cell lines. The MP-12 strain
originated from the passage 12 attenuated ZH548 isolate from
the serum of a febrile human case during the Egyptian RVFV
outbreak in 1977 (Caplen et al., 1985). The MP-12 strain and
several of its derivatives have since been researched and pursued
as vaccine candidates in the US (Kortekaas, 2014). The SA01-
1322 strain was originally isolated from a mosquito in Saudi
Arabia during the 2000–2001 RVFV outbreak which resulted in
more than 2000 human deaths and signiﬁcant livestock deaths
(Al-Hazmi et al., 2003; Madani et al., 2003). RVFV is listed as
a category A high-priority pathogen by the National Institute
of Allergy and Infectious Diseases and a select agent by the
U.S. Department of Health and Human Services and the U.S.
Department of Agriculture, and requires work to be performed
at a biosafety level 3+ (BSL-3+) high biosecurity containment
facility. The MP-12 strain is excluded from the select agent list
and considered a BSL-2 agent in the US, which makes it a
convenient model virus to work with. This work serves as a guide
for future animal model and risk assessment studies concerning
this important zoonotic pathogen.
Materials and Methods
Virus
The attenuated RVFV MP-12 strain was provided by the United
States Army Medical Research Institute for Infectious Diseases.
The virulent Saudi Arabia isolate SA01-1322 (Miller et al.,
2002) was provided by R. Bowen, Colorado State University
through B. Miller, Centers for Disease Control, Fort Collins, CO,
USA. Experiments with the SA01-1322 strain were performed at
Kansas State University’s Biosecurity Research Institute BSL-3+
laboratory, and the MP-12 experiments were completed outside
of the high-containment facility at a BSL-2 laboratory. Both virus
strains were propagated in mammalian-derived cell cultures and
low passage stocks were used for experiments.
Cell Lines
The African green monkey Vero cell line is a clone from the
Middle America Research Unit (MARU). The frog (Xenopus
laevis) kidney cell line was obtained from Jane Homan at the
University of Wisconsin, and is commercially available through
American Type Culture Collection (ATCC), Manassas, VA,
USA. The sheep (Ovis aries, breed unknown), calf (Bos taurus,
breed: black angus), pig (Sus scrofa, breed: duroc), American
pronghorn (Antilocapra americana), elk (Cervus elaphus), mule
deer (Odocoileus hemionus), white-tailed deer (O. virginianus),
and coyote (Canis latrans) cell lines were initiated and
established by the Arthropod-Borne Animal Diseases Research
Unit (ABADRU), Manhattan, KS, USA from tissues derived
from specimens donated to ABADRU or the Wyoming State
Veterinary Diagnostic Laboratory. Brieﬂy, primary lung and
kidney cells were harvested by manual homogenization, and
then pressed through tissue sieves. Subsequent cells were washed
and resuspended in 199E media (Life Technologies, Grand
Island, NY, USA) supplemented with 10% gamma-irradiated
fetal bovine serum (FBS; Sigma–Aldrich, St. Louis, MO, USA)
and 1x antibiotics (penicillin and streptomycin)-antimycotic
(amphotericin B; PSF; Life Technologies, Grand Island, NY,
USA). Non-adherent cells were removed and media replaced
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at weekly intervals. Cell lines were screened for bacteria, fungi,
and mycoplasma contamination by cultivation methods or using
the MycoTect kit (Life Technologies, Grand Island, NY, USA).
Speciﬁc tests for the presence of bovine viral diarrhea and
bluetongue viruses were also performed. Certain cell lines were
additionally screened for other viral contaminants by electron
microscopy using negative staining techniques. All of the cell
lines used for this study were negative for contaminants included
in the screening processes mentioned. Lung cultures were a
mixture of ﬁbroblastic and endothelial like cells. All brain cell
lines used in this study were prepared similar to the lung
and kidney cell lines as described above and then transformed.
Transformation consisted of transfection of primary cultures
with an expression plasmid carrying the simian virus 40 genome
(pBRSV, ATCC 45019) using Lipofectamine 2000 reagent (Life
Technologies, Grand Island, NY, USA) per the manufacturer’s
instructions. Medium was changed 48 h later to OptiMEM
(Life Technologies, Grand Island, NY, USA) and 10% FBS,
and the cells were grown for an additional 1 to 2 weeks,
when clusters of cells showing loss of contact inhibition and
an increased rate of cell division were selected using cloning
cylinders. All cell lines were maintained at 5% CO2, 37◦C
with the exception of the frog cell line which was kept at 28–
30◦C.
Viral Growth Kinetics
Overnight cell cultures (∼90% conﬂuent) were infected at 0.1
multiplicity of infection (MOI) with either the MP-12 or SA01-
1322 RVFV strains. Virus was adsorbed for 1 h then monolayers
were washed and fresh media added. Time course samples were
collected at 0, 6, 12, 24, 36, and 48 h post infection. Cells and
culture supernatant were collected separately for intracellular
and extracellular virus titration, respectively. Total virus was
measured by collecting both cells and culture supernatant
simultaneously. Samples were subjected to three freeze/thaw
cycles and stored at −80◦C until analysis. Standard plaque assays
on Vero MARU cells were performed to calculate titers in plaque
forming units per ml (pfu/ml).
RNA Extraction and Real Time Reverse
Transcription Polymerase Chain Reaction
(rRT-PCR)
Total RNA was extracted from virus time course samples using
TRIzol-LS reagent (Life Technologies, Grand Island, NY, USA)
and the magnetic-bead based capture MagMAX viral RNA
isolation kit (Life Technologies, Grand Island, NY, USA). Brieﬂy,
100 µl of aqueous phase was added to 90 µl of isopropanol
and 10 µl bead mix. Total sample RNA was washed four times
and eluted in 30 µl of elution buﬀer by use of the automated
KingFisherMagnetic Particle Processor (Thermo Fisher Scientiﬁc
Inc., Waltham, MA, USA). Sequences of primers and probes
directed toward a region of the large (L) genome segment of
MP-12 or ﬁeld strains of RVFV have been published previously
and were used to estimate viral RNA levels (Bird et al., 2007;
Wilson et al., 2013). Beta actin (Moniwa et al., 2007) was used
as a reference gene to calculate the relative levels of viral RNA
among samples using the comparative Ct method (Delta Delta
Ct). The relative levels of extracellular viral RNA were calculated
by comparison to the beta actin levels in the intracellular
fraction of the same sample. Beta actin and MP-12 or RVFV
primer and probe sets were ran as a duplex real time reverse
transcription polymerase chain reaction (rRT-PCR) assay using
5 µl sample RNA template and the one-step AgPath ID rRT-PCR
kit (Life Technologies, Grand Island, NY, USA) under conditions
previously published (Wilson et al., 2013). The primer and probe
sequences are listed in Table 1 and locations of the primer and
probes on the RVFV L segment are shown in the Supplementary
Figure S1.
Results
A total of nine diﬀerent animal-derived cell lines indigenous
to North America were evaluated, including domestic ruminant
(sheep and calf), wild ruminant (white-tailed deer, mule deer,
pronghorn, elk), and non-ruminant (pig, coyote, frog) species.
In both animals and humans, RVFV typically targets the liver
and spleen, and can be neuroinvasive; however, it is also known
to replicate in a variety of other tissues and cells (Ikegami
and Makino, 2011). Cell lines derived from kidney, brain,
and lung tissues were compared due to the availability of
these tissues across multiple animal species. The attenuated
RVFV MP-12 strain was used for initial comparisons of virus
replication in various cell lines, as it does not require work at
a high biosecurity level facility. Viral growth kinetics were then
performed with a representative set of cell lines with the virulent
TABLE 1 | Primer and probes for real time reverse transcription
polymerase chain reaction (RT-PCR).
Primer/Probe Position Sequence 5′–3′ Reference
Rift Valley fever
virus (RVFV)-L-
forward
2912–2933 TGA-AAA-TTC-CTG-AGA-
CAC-ATG-G
Bird et al.
(2007)
RVFV-L-reverse 2981–3001 ACT-TCC-TTG-CAT-CAT-
CTG-ATG
RVFV-L-probe 2950–2977 (CAL Red)a
CAA-TGT-AAG-GGG-CCT-
GTG-TGG-ACT-TGT-G
(Iowa Black)b
MP12-L-
forward
3296–3316 CCT-CAC-TAT-TAC-ACA-
CCA-TTC
Wilson
et al. (2013)
MP12-L-
reverse
3436–3453 ATC-ATC-AGC-TGG-GAA-
GCT
MP12-L-probe 3371–3385 (FAM)a
CTG-AGA-TGA-GCA-AGA
(Iowa Black)b
Beta
actin-forward
BTC-CTT-CCT-GGG-CAT-
GGA
Moniwa
et al. (2007)
Beta
actin-reverse
GRG-GSG-CGA-TGA-TCT-
TGA-T
Beta
actin-probe
(CY5)a
TCC-ATC-ATG-AAG-TGY-
GAC-GTS-GAC-A (Iowa
Black)b
aFluorescent reporter dye; bQuencher.
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SA01-1322 strain RVFV. The brain cell lines from domestic and
wild ruminants supported the most eﬃcient viral replication
of the MP-12 strain. Using a MOI of 0.1, viral titers in the
ruminant-derived brain cell lines peaked around 24 hpi and
MP-12 titers ranged between 105 and 107 pfu/ml (Figure 1A).
Replication kinetics of MP-12 were more rapid in the calf,
white-tailed, and mule deer cell lines, with titers nearly 102
to 103 pfu/ml higher at 6 hpi compared to titers from sheep,
pronghorn, and elk cell cultures (Figure 1A). Replication kinetics
of MP-12 in the pig brain cell line was signiﬁcantly delayed
compared to the ruminant brain cells. Expansion of MP-12 in
the pig brain cells did not occur until after 12 hpi and only
a titer around 103 pfu/ml was achieved by 48 hpi which was
more than 102 pfu/ml lower than the lowest titer observed at
the same time point among the ruminant-derived brain cell
lines (Figure 1A). Conversely, replication kinetics and titers of
the SA01-1322 strain were more consistent among the white-
tailed deer, sheep, and pig brain cell lines tested (Figure 1B).
Titers averaged around 103 pfu/ml by 6 hpi and then peaked
around 105 to 106 pfu/ml between 24 and 36 hpi, with the
white-tailed deer cell line supporting slightly higher virus titers
(Figure 1B).
The replication kinetics of the MP-12 strain were slightly
slower in the kidney cell lines compared to the brain cell lines
with titers peaking after 36–48 hpi (Figure 1C); however, high
titers were still achieved in these cell lines. Titers of MP-12 in the
white-tailed deer and sheep kidney cell lines reached 107 pfu/ml,
while the pig and frog kidney cell lines supported MP-12 titers of
105 and 106 pfu/ml, respectively (Figure 1C). Similar replication
kinetics and titers in the range of 105 pfu/ml were observed
for the SA01-1322 strain among the white-tailed deer, sheep,
and pig kidney cell lines (Figure 1D). Compared to the brain
cell line, SA01-1322 peak titers were about 101 pfu/ml lower in
white-tailed deer kidney cells (Figures 1B,D).
Although RVFV is not typically associated with respiratory
disease, results from this study demonstrated that MP-12 was
capable of replicating in three diﬀerent lung cell lines. Lung-
derived cell lines consisted of a heterogeneous mixture of cells
FIGURE 1 | Rift Valley fever virus (RVFV) replication kinetics in
North American livestock and wildlife cell lines. Cell cultures
derived from brain (A,B), kidney (C,D), and lung (E) were infected
with MP-12 (A,C,E) or SA01-1322 (B,D) strains at 0.1 multiplicity
of infection (MOI) and the viral titers were calculated by standard
plaque assay at the indicated hours post infection (hpi). The mean
of at least three biological replicates are represented with 95%
confidence intervals.
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showing epithelial and ﬁbroblast-like morphology. Titers in
the lung cells peaked around 103 pfu/ml in pig and coyote
cells, and 107 pfu/ml in white-tailed deer cells by 36 hpi
(Figure 1E). Infectious virus was detected by 12 hpi in the
white-tailed deer lung cells and by 24 hpi in the coyote lung
cell line (Figure 1E). The pig lung cell line had the most
delayed viral kinetics with virus not detected until 36 hpi
(Figure 1E). Overall, the SA01-1322 strain viral kinetics and
titers were relatively consistent with little variation among
the cell lines tested, while the MP-12 strain exhibited more
variability among species and the tissues the cell lines were
derived.
The L genome segment of RVFV was targeted to monitor
relative viral RNA levels in the time course samples. In general,
relative viral RNA levels correlated with the kinetics of virus
titers; however, the amount of viral RNA did not always directly
correspond to the infectious viral titer (Figures 1 and 2). For
example, SA01-1322 RNA levels in the brain cell lines (Figure 2B)
were lower than SA01-1322 RNA in kidney cells (Figure 2D).
Levels of MP-12 RNA were generally higher than the RNA
levels produced by the SA01-1322 strain (Figures 2A–D). This
observation could be explained by more eﬃcient primer binding
and ampliﬁcation of the MP-12 RNA template compared to the
SA01-1322 strain, although no mutations were detected in the
primer or probe binding sites by sequencing of the original
virus stock used in these experiments (Supplementary Figure
S1). Alternatively, this could be due to eﬃcient expression,
but less eﬃcient packaging of infectious virus particles, or
more defective interfering particles incorporated in the MP-
12 compared to the SA01-1322 virus strain. Based on these
results, the amount of viral RNA produced in cells determined
by rRT-PCR does not accurately correlate to infectious virus
titer, but can be useful for monitoring viral replication kinetics
and perhaps estimating infectious titer for a deﬁned viral
isolate.
In order to determine the ability of RVFV to be eﬃciently
released from infected cells, extracellular virus from the
culture supernatants and intracellular virus from cells was
FIGURE 2 | Relative viral RNA levels in North American livestock
and wildlife cell lines. Real time reverse transcription polymerase
chain reaction (RT-PCR) was performed on time point samples from
brain (A,B), kidney (C,D), and lung (E) cell lines infected with
MP-12 (A,C,E) or SA01-1322 (B,D) strains. Expression of viral RNA
was calculated relative to beta actin using the comparative Ct
method. The mean of at least three biological replicates are
represented with SEs.
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also compared. Although not statistically signiﬁcant, there
were some observed diﬀerences between the two fractions
from certain cell lines that were evaluated. In particular, the
brain cell lines derived from sheep, calf, and white-tailed deer
which supported eﬃcient viral replication had slightly higher
extracellular virus titers compared to intracellular (Figure 3A
and data not shown), while the inverse was observed in cell
lines with more delayed viral kinetics such as the coyote lung
and pig kidney cell lines (Figure 3C and data not shown). The
diﬀerence between intra- and extracellular viral titers was not
as clearly observed with the viral RNA levels (Figures 3B,D).
While lower MP-12 titers were observed in the coyote cell
line compared to the sheep cells (Figures 3A,C), the viral
RNA was higher in the coyote cells than the sheep cells
(Figures 3B,D).
Discussion
Domestic ruminants are the primary hosts for RVFV (Pepin
et al., 2010); however, there is evidence of wild ruminant
species in endemic regions also being infected including buﬀalo,
waterbuck, impala, and kudu (Evans et al., 2008; LaBeaud
et al., 2011; Britch et al., 2013). There is an abundance of
similar wild ruminants, such as the American pronghorn,
elk, and multiple deer species, widely distributed throughout
the US. The overlap of wildlife habitats with livestock and
human populations increases the risk for transmission and
dissemination of zoonotic arboviruses like RVFV. Speciﬁcally,
white-tailed deer are a common source of mosquito blood
meals (Apperson et al., 2004; Molaei et al., 2008, 2009a,b), and
serve as reservoirs for other arboviruses such as Jamestown
Canyon virus which aﬀects humans, Cache Valley, and epizootic
hemorrhagic disease viruses of sheep and cattle (Molaei et al.,
2009a; Allison et al., 2010). Results from the current study
demonstrated that wild ruminant-derived cell lines, especially
white-tailed deer, supported eﬃcient replication of two diﬀerent
strains of RVFV to high titers. This could have a signiﬁcant
impact on RVFV ecology as well as on the deer farming
industry. Thus, these wild ruminants should be considered
as high priority candidates for further investigation including
competency and transmission studies. Controlled infection
studies with white-tailed deer have been accomplished with other
viruses, and plans for a RVFV infection study are currently in
progress.
Seroprevalence studies have shown RVFV exposure of a
number of non-ruminant animals. Evidence in Egypt found
seroprevalence in domestic pigs, and also in the desert
warthog (Evans et al., 2008). Experimentally, pigs appear to
be clinically resistant (Easterday and Murphy, 1963; Easterday,
1965; Shimshony and Barzilai, 1983), while others have shown
that resistance is dose-dependent (Scott, 1963). Feral swine
are often of epidemiological concern because they are carriers
of a variety of parasites and microbial diseases which could
potentially threaten the health of domestic livestock, wildlife,
and humans (Mayer and Brisbin, 1991). Furthermore, their
FIGURE 3 | Comparison of intracellular and extracellular virus in North American livestock and wildlife cell lines. Intracellular and extracellular virus titers
(A,C) and relative viral RNA levels (B,D) are shown. The mean of at least three biological replicates are represented.
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numbers and distribution continue to grow in the US (Mayer
and Brisbin, 1991). Swine are not known to play a signiﬁcant
role in RVFV epidemiology in endemic countries (Olaleye
et al., 1996); however, infection of pigs could have signiﬁcant
economic repercussions related to pork production and trade.
Although replication of the MP-12 strain was the most inhibited
in the pig cell lines, the virulent SA01-1322 RVFV strain
replicated nearly as eﬃciently in the pig cell lines as in
the sheep cell lines tested. Therefore, further investigation
and assessment of swine for RVFV susceptibility may be
warranted.
Some experimental evidence exists that other non-ruminant
species such as domestic horses, dogs, and cats may be mildly
susceptible to RVFV in endemic countries, while aves, reptiles,
and amphibians appear to be refractory (Olive et al., 2012).
We tested a coyote cell line since the distribution of these
animals’ spans throughout North America and it is possible that
coyotes could become exposed by scavenging infected livestock
or wildlife, or by infected mosquitoes. Although less eﬃciently
than in the other cell lines tested, the MP-12 strain did replicate
in the coyote-derived lung cell lines. Unfortunately, other tissues
from coyote were not available for testing. Interestingly, the frog
kidney cell line was also found to support RVFV replication.
Wetland areas contain a variety of amphibians and reptiles,
and are ideal breeding grounds for mosquitoes known to feed
on them (Burkett-Cadena et al., 2008; Bingham et al., 2014).
An enzootic cycle has recently been demonstrated between
mosquitoes and snakes for eastern equine encephalitis virus
(White et al., 2011; Bingham et al., 2012; Graham et al., 2012). In
an analysis of blood meal sources of mosquitoes collected from
Kenya during the 2006–2007 RVFV outbreak, 13% of one of the
predominant infected mosquito species was found to have fed
on frogs (Lutomiah et al., 2014). Therefore, it may be important
not to completely rule out these animals as playing a potential
role in the viral life cycle of RVFV. In summary, it may be
necessary to consider a wide variety of animals when assessing
the risk of infection, dissemination, and maintenance of this
important zoonotic arbovirus. Although especially challenging
under high biosecurity conditions, controlled experimental
animal studies with wildlife species such as white-tailed deer
and coyotes have been achieved with other pathogen models,
and are therefore not out of the realm of possibility to pursue
further.
Finally, it is interesting to note that three diﬀerent lung cell
lines were permissive to RVFV infection, even though RVFVis
is typically not associated with respiratory disease. Infection by
aerosol transmission of RVFV has occurred in the laboratory
environment; however, no human-to-human transmission has
ever been documented (CDC, 2013). Intranasal challenge and
aerosol exposure models with RVFV in mice and monkeys
results in severe neuropathology and death (Bales et al., 2012;
Reed et al., 2013; Hartman et al., 2014). In a recent sheep
model challenged subcutaneously, coughing was observed and
low levels of RVFV (less than 102 pfu/mL) were detected in
nasal swabs from some of the infected animals; however, no signs
of viremia were detected from any of the uninfected control
animals housed alongside the challenged animals throughout
the 21 days study (unpublished data). Although it may be
possible for airborne transmission to occur, it is more likely to
occur through direct contact with infected tissues and bodily
ﬂuids. Nonetheless, creation and exposure to aerosols of RVFV
should be avoided due to the severe pathology associated with
this route of infection. Further investigation is necessary for
understanding better the potential risk of aerosol transmission of
RVFV.
Conclusion
The objective of the current study was to build a foundation
for future in vivo host competency studies and guide statistical
risk modeling for this high-consequence zoonotic pathogen.
The results presented here suggest RVFV could potentially
infect a wide range of domestic livestock and wildlife native
to North America. All of the cell lines tested in the current
study were permissive and susceptible for RVFV replication,
especially ruminant-derived cell lines. Based on these results
and serology surveys of wild ruminants in endemic countries,
deer and other wild ruminant species should be given high
priority for further investigations. It is currently unknown
whether these animals are competent hosts for RVFV, or what
role they could play in the dissemination of this virus. In the
event that RVFV were introduced to the US and wildlife was
capable of becoming reservoirs for this pathogen, controlling
the spread of RVFV would be diﬃcult, if not impossible. Not
only is RVFV a threat to both human and animal health,
but the establishment of this pathogen would have costly
economic impact related to livestock production and trade.
Thus, expanding research to investigate competence of potential
wildlife hosts in the US remains critical in order to plan
eﬀective response and control strategies if an introduction were
to occur.
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